|Bid||89.07 x 1000|
|Ask||89.98 x 800|
|Day's Range||88.07 - 90.61|
|52 Week Range||61.85 - 96.17|
|Beta (5Y Monthly)||1.08|
|PE Ratio (TTM)||37.00|
|Earnings Date||Feb 14, 2024 - Feb 19, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||95.00|
Subscribe to Yahoo Finance Plus to view Fair Value for ITGR
BD's (BDX) FDA approval for MiniDraw will likely reshape diagnostic testing by providing a unique design that offers blood collection at any convenient location with reduced volume.
AMN Healthcare's (AMN) collaboration is likely to bolster its portfolio of products and simplify the language procurement process for customers.
OPKO Health's (OPK) potential in Rayaldee raises optimism about the stock.